# SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients

> **NCT01222819** · PHASE4 · TERMINATED · sponsor: **Rabin Medical Center** · enrollment: 120 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** filgrastim

## Key facts

- **NCT ID:** NCT01222819
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-04
- **Target enrollment:** 120 (ACTUAL)
- **Why stopped:** Physycians' refusal to continue the study
- **Last updated:** 2016-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01222819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01222819, "SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01222819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*